Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 1.93 CAD -3.02% Market Closed
Market Cap: 52.9m CAD

Covalon Technologies Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Covalon Technologies Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Net Income (Common)
CA$2.3m
CAGR 3-Years
-49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Net Income (Common)
-$9.2m
CAGR 3-Years
44%
CAGR 5-Years
13%
CAGR 10-Years
-2%
Repare Therapeutics Inc
NASDAQ:RPTX
Net Income (Common)
-$109.9m
CAGR 3-Years
6%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Net Income (Common)
$77.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Net Income (Common)
-$306.3m
CAGR 3-Years
-40%
CAGR 5-Years
-63%
CAGR 10-Years
-62%
Spectral Medical Inc
TSX:EDT
Net Income (Common)
-CA$21.4m
CAGR 3-Years
-28%
CAGR 5-Years
-21%
CAGR 10-Years
-10%
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
52.1m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.77 CAD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Net Income (Common)?
Net Income (Common)
2.3m CAD

Based on the financial report for Jun 30, 2025, Covalon Technologies Ltd's Net Income (Common) amounts to 2.3m CAD.

What is Covalon Technologies Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-49%

The average annual Net Income (Common) growth rates for Covalon Technologies Ltd have been -49% over the past three years .

Back to Top